People · Operator
Named in public records as an officer, director or promoter · active 2009–2010 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Cellumen, Inc. | — | Biotechnology | Pre-Seed | $1.6M | $13.7M | 2009 |
Jack L. Reynolds at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Jack L. Reynolds on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| D. Lansing Taylor | 1 | 4 |
| LeRoy L. Metz | 1 | 1 |
| Dean L. Miller | 1 | 1 |
| Donald P. Taylor | 1 | 1 |
| James L. Datin | 1 | 1 |
| Matthew L. Malenfant | 1 | 1 |
| Patricia A. Johnston | 1 | 1 |
| Franklyn L. Prendergast | 1 | 1 |
| Rosemary L. Mazanet | 1 | 1 |
| Gregory L. Finerty | 1 | 1 |
| Albert L. Gough | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.